HYPERSENSITIVITY is the #10 most commonly reported adverse reaction for APREPITANT, manufactured by Merck Sharp & Dohme LLC. There are 1,133 FDA adverse event reports linking APREPITANT to HYPERSENSITIVITY. This represents approximately 1.5% of all 73,587 adverse event reports for this drug.
Patients taking APREPITANT who experience hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
HYPERSENSITIVITY1,133 of 73,587 reports
HYPERSENSITIVITY is a less commonly reported adverse event for APREPITANT, but still significant enough to appear in the safety profile.
Other Side Effects of APREPITANT
In addition to hypersensitivity, the following adverse reactions have been reported for APREPITANT:
HYPERSENSITIVITY has been reported as an adverse event in 1,133 FDA reports for APREPITANT. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is HYPERSENSITIVITY with APREPITANT?
HYPERSENSITIVITY accounts for approximately 1.5% of all adverse event reports for APREPITANT, making it a notable side effect.
What should I do if I experience HYPERSENSITIVITY while taking APREPITANT?
If you experience hypersensitivity while taking APREPITANT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.